Trial Details

Not Recruiting
Basic Information
Clinical ID c5052
Identifier IRCT20101107005123N3
Trial Title Evaluation of the effect of silymarin in patients with inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory Bowel Disease. Noninfective inflammatory bowel disease;K50-K52
Interventions Intervention 1: Intervention group: Silymarin tablets (Gol Daro Company) with a dose of 5 mg/kg in divided doses three times a day for three months on a daily basis. Intervention 2: Control group: Three times a day placebo for three months on a daily basi
Participant Information
Sponsor Mashhad University of Medical Sciences
City NULL
Country/Region Iran
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, CHILD, TEENAGER
Study Design
Study Type interventional
Phase NULL
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL